Skip to main
HR

HR Stock Forecast & Price Target

HR Analyst Ratings

Based on 8 analyst ratings
Hold
Strong Buy 13%
Buy 25%
Hold 63%
Sell 0%
Strong Sell 0%

Bulls say

Healthcare Realty Trust Inc. has demonstrated robust financial performance, reporting a 4Q25 same-store net operating income (NOI) growth guidance of 5.5% and 4.8% for the full year 2025, indicating significant growth prospects as occupancy rates improve. The company has also achieved a notable occupancy improvement to 92.1% by year-end, which enhances its revenue-generating capabilities in the competitive medical office sector. Additionally, Healthcare Realty Trust's leverage has been effectively managed, with a 5.4x levered balance sheet at 4Q25, positioning the company favorably for risk-adjusted returns through its long-term lease and mortgage strategy.

Bears say

Healthcare Realty Trust Inc. has experienced a decline in its IFRS net asset value per unit (NAVPU), which fell 6% to $17.74, reflecting ongoing challenges in its financial performance. Future projections for funds from operations per unit (FFOPU) and adjusted funds from operations per unit (AFFOPU) show expectations of 10%-20% below prior consensus estimates, indicating potential stagnation with a projected compound annual growth rate (CAGR) of -4% to -8% from 2025 to 2027. Additionally, reported recurring FFOPU dropped 4.4% quarter-over-quarter and 1.5% year-over-year, signaling persistent revenue pressures that may hinder the company’s overall performance.

HR has been analyzed by 8 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 25% recommend Buy, 63% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Healthcare Realty Trust Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Healthcare Realty Trust Inc (HR) Forecast

Analysts have given HR a Hold based on their latest research and market trends.

According to 8 analysts, HR has a Hold consensus rating as of Mar 21, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $18.88, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $18.88, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Healthcare Realty Trust Inc (HR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.